Skip to main content
All lobbying filings

AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION

Lobbying for AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 13, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Illinois

Official filing document

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 3
 Lobbying activity 2
Medicare/Medicaid

- US Congress: Signed on ASM Letter RE: Urge Congressional action to stop a portion of the recently finalized rule published by the Centers for Medicare & Medicaid Services (CMS) on October 31st (90 Fed. Reg. 32352 et seq.), that reduces the work Relative Value Units (RVUs) and intra-service time for all non-time-based codes by 2.5 percent in 2026, with additional reductions expected every 3 years indefinitely. - US House of Representatives: Signed on ASM Letter RE: Commend House Appropriations Committee for unanimously adopting an amendment that would halt funding for implementation of the Medicare Wasteful and Inappropriate Service Reduction (WISeR) Model in the Fiscal Year 2026 appropriations legislation - US House of Representatives: Signed on ASM Letter Re: Support of H.R. 6160, the Strengthening Medicare for Patients and Providers Act

Health Issues

- US House of Representatives: Signed on ASM Letter RE: Support for H.R. 5509, the Safe Step Act - US Senate: Signed on ASM Letter RE: Support for S. 2903, the Safe Step Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem